Terazosin in Hypertension Management

Place in Hypertension Treatment

• The American College of Cardiology recommends that alpha-1 blockers like terazosin are not used as first-line agents for hypertension, with a usual dose range of 1-20 mg/day, administered once or twice daily 1
• Alpha-1 blockers may be considered as second-line agents in patients with concomitant benign prostatic hyperplasia (BPH) 1

Safety Concerns and Adverse Effects

• In men with hypertension and cardiac risk factors, alpha blockers like doxazosin (similar to terazosin) have been associated with a higher incidence of congestive heart failure compared to other antihypertensive agents 2, 3

Clinical Recommendations

• The American College of Cardiology guidelines suggest that for primary hypertension management, terazosin should not be used as a first-line agent due to its side effect profile and the availability of more effective alternatives 1
• In patients with hypertension and cardiac risk factors, separate management of hypertension with other agents may be necessary 2, 3